Black Friday Special: Could 12/1 be the most profitable event in crypto history?
Man voted "#1 Most Trusted Crypto Expert" shares his latest buy recommendation.
Click For Special
Jennifer B. Damico, insider at Pfizer
Jennifer B. Damico Insider Alerts

Get notified the next time Jennifer B. Damico buys or sells Pfizer stock. Enter your email address below to get our daily insider buying and selling report.

Jennifer B. Damico Insider Information

SVP of Pfizer
Jennifer Damico is Vice President, Corporate Audit, Pfizer Inc, reporting to the Audit Committee of the Board of Directors and the Chief Financial Officer. She is responsible for leading 100 audit professionals primarily based in New York, New Jersey, Connecticut, Pennsylvania, Mumbai, Dublin and Beijing. Corporate Audit provides independent, Pan-Pfizer corporate regulatory audit and oversight of processes and systems spanning the company's operating model including: discovery, development, manufacturing, commercial sales & marketing activities, finance and information technology.

Jennifer joined Pfizer in 1992 and has held positions of increasing responsibility in Audit, Information Technology, and Finance. She joined the company as a Senior Internal Auditor and was promoted to Audit Manager in 1994. In 1997, Jennifer joined the Corporate Information Technology Division as Director of Finance and Controller. In 2001, she rejoined Internal Audit as an Audit Director and was promoted to Senior Director, Strategy, Governance and Operations in 2008. Jennifer served as the Program Management Office (PMO) Lead for the Finance One transformation program and led the finance integration for the King acquisition. In 2010, she became Vice President, Finance Portfolio Management & Optimization, and established a new organization to provide centralized, customer-focused project & change management as well as coordination of finance integration and divestiture activities which more recently included supporting the Nutritional and Animal Health divestitures. Prior to joining Pfizer, she worked as a senior auditor for Arthur Andersen.

Jennifer holds a Master of Business Administration degree from Pace University and is a Certified Public Accountant. She is married with two children Ryan, 15 and Courtney, 13 and lives in Long Island, NY.

What is Jennifer B. Damico's net worth?

The estimated net worth of Jennifer B. Damico is at least $617,220.00 as of July 30th, 2021. Ms. Damico owns 11,430 shares of Pfizer stock worth more than $617,220 as of November 27th. This net worth approximation does not reflect any other investments that Ms. Damico may own. Learn More.

How do I contact Jennifer B. Damico?

The corporate mailing address for Ms. Damico and other Pfizer executives is 235 EAST 42ND STREET, NEW YORK NY, 10017. Pfizer can also be reached via phone at (212) 733-2323.

Has Jennifer B. Damico been buying or selling shares of Pfizer?

Jennifer B. Damico has not been actively trading shares of Pfizer during the past quarter. Most recently, Jennifer B. Damico sold 1,661 shares of the business's stock in a transaction on Friday, August 13th. The shares were sold at an average price of $48.30, for a transaction totalling $80,226.30.

Who are Pfizer's active insiders?

Pfizer's insider roster includes Jennifer Damico (SVP), and Jennifer Damico (SVP).

Are insiders buying or selling shares of Pfizer?

In the last year, insiders at the biopharmaceutical company sold shares 4 times. They sold a total of 156,661 shares worth more than $7,798,426.30. The most recent insider tranaction occured on November, 11th when insider John D Young sold 150,000 shares worth more than $7,509,000.00. Insiders at Pfizer own 0.1 % of the company.

Information on this page was last updated on 11/11/2021.

Jennifer B. Damico Insider Trading History at Pfizer

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/13/2021Sell1,661$48.30$80,226.30View SEC Filing Icon  
7/30/2021Sell2,500$42.86$107,150.0011,430View SEC Filing Icon  
5/5/2021Sell2,500$40.82$102,050.0013,748View SEC Filing Icon  
6/5/2020Sell2,181$36.13$78,799.537,542View SEC Filing Icon  
4/29/2020Sell2,181$38.35$83,641.359,647View SEC Filing Icon  
See Full Table

Jennifer B. Damico Buying and Selling Activity at Pfizer

This chart shows Jennifer B Damico's buying and selling at Pfizer by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Pfizer Company Overview

Pfizer logo
Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Read More

Today's Range

Now: $54.00
Low: $53.25
High: $54.94

50 Day Range

MA: $45.34
Low: $41.32
High: $54.00

2 Week Range

Now: $54.00
Low: $33.36
High: $54.94

Volume

66,561,304 shs

Average Volume

31,100,449 shs

Market Capitalization

$303.09 billion

P/E Ratio

16.07

Dividend Yield

3.07%

Beta

0.72
Black Friday Special: Could 12/1 be the most profitable event in crypto history?
Man voted "#1 Most Trusted Crypto Expert" shares his latest buy recommendation.
Click For Special